Short-term results in a population based study indicate advantage for minimally invasive rectal cancer surgery versus open
View abstract on PubMed
Summary
This summary is machine-generated.Minimally invasive surgery (MIS) for rectal cancer is as effective as open surgery (OPEN) for achieving adequate cancer resection. MIS also demonstrated better short-term outcomes, including lower mortality and shorter hospital stays.
Area Of Science
- Oncology
- Surgical Oncology
- Gastroenterology
Background
- Rectal cancer treatment often involves surgery.
- Minimally invasive surgery (MIS) and open surgery (OPEN) are common approaches.
- Comparing their effectiveness in cancer resection is crucial.
Purpose Of The Study
- To compare the non-inferiority of MIS versus OPEN surgery for rectal cancer.
- To assess the adequacy of cancer resection in a population-based setting.
- To evaluate short-term outcomes associated with each surgical approach.
Main Methods
- A population-based study included 9,464 patients with rectal cancer from 2012-2018.
- Curative surgery (MIS or OPEN) was performed.
- Key outcomes included positive circumferential resection margin (CRM < 1 mm) and R1 resection.
Main Results
- Circumferential resection margin positivity was 3.8% for MIS vs. 5.4% for OPEN.
- R1 resection rates were 2.8% for MIS vs. 4.4% for OPEN.
- No significant differences in adjusted analyses; MIS showed reduced mortality, re-admissions, and shorter length of stay.
Conclusions
- Minimally invasive surgery (MIS) is non-inferior to open surgery (OPEN) for rectal cancer resection adequacy.
- MIS offers favorable short-term outcomes compared to OPEN surgery.
- These findings support MIS as a viable option for rectal cancer treatment.

